Institute for International Research

Know how to achieve

Main menu

My IIR

Login form

Sign Up

Registration

Online Registration is open!

Customer Service

Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200


Need Technical Assistance With this Website?
Send an email to IIR's Web Department

Send To A Friend

Invite a colleague to join you at this event

Add Event To Calendar

Save the event dates in your Outlook calendar

Find another IIR Event

Event Search Form by Industry

Formulation & Forced Degradation Strategies for Biomolecules

The only conference tying analytics into formulation
considerations and delivery techniques!

March 19 - 21, 2007 | Hilton San Diego Mission Valley, | San Diego, CA

Event Overview

Event Overview

Online Documentation Now Available!

Dear Analytical Scientists and Formulators:

Are you looking for more efficient ways to analyze and
characterize biomolecules for formulation and stability?

As an Analytical Scientist working on troubleshooting Stability-Indicating Assays, we encourage you to review these particular areas of the conference:

  • AM Workshop, March 19: Stability-Indicating Assay Development Methodology
  • PM Workshop, March 19: Analytical Strategies to Predict, Detect, and Control Extractables and Leachables
  • Track B, March 20: Design and Master Forced Degradation Strategies (featuring case studies and panel discussions)
  • Afternoon Plenary, March 20: Physical Characterization of PEGylated Peptides
  • Morning Plenary, March 21: Cutting-Edge High Throughput Analytical Testing Techniques
  • Track B, March 21: Orthogonal Methods for Degradant Analysis (featuring case studies and panel discussions)

As a Formulation Scientist working on troubleshooting Formulation Development & Delivery, we encourage you to review these particular areas of the conference:

  • AM Workshop, March 19: Stability-Indicating Assay Development to Predict Formulation Performance
  • PM Workshop March 19: Predict, Detect, and Control Extractables and Leachables- How will your delivery device effect this?
  • Track A, March 20: Phases & Stages- Key Formulation Approaches for Successful Development
  • Afternoon Plenary, March 20: Extrapolation of Results from Forced Degradation to Practical Formulation Development
  • Morning Plenary, March 21: Optimize Protein Formulation with the Use of Second Virial Coefficient Measurements
  • Track A, March 21: Drug Delivery and Formulation (featuring case studies and panel discussions)

FEATURED SPEAKERS

OPTIMIZING THE PROTEIN PURIFICATION PROCESS .

Prathima Acharya, PhD,
Sr. Scientist, Analytical & Formulation Development
DIOSYNTH BIOTECHNOLOGY


NEW TECHNOLOGIES!
.

Wm. Randy Forsyth, PhD,
Sr. Scientist, Emerging Sciences & Technology
TRANSFORM PHARMACEUTICALS




.Larry J. DeLucas, OD, PhD, DSc. (hon.),
Professor and Director of the Center for Biophysical Sciences and Engineering,
THE UNIVERSITY OF ALABAMA AT BIRMINGHAM


SPOTLIGHT ON AGGREGATION… .

Wei Wang, PhD,
Associate Research Fellow- Biologics,
PFIZER



FORMULATION DEVELOPMENT AND ANALYSIS…
.

Rob Simler, PhD,
Staff Scientist,
GENZYME CORPORATION


PROVIDING SOLUTIONS TO YOUR KEY ANALYTICAL &
FORMULATION CHALLENGES:

• Differences in Early vs. Late Stage Development
• Protein Aggregation
• Lyophilized Formulations
• Forced Degradation Testing
• Best Practice Degradant Analysis
• High Throughput Technology
• Drug Delivery
• PEGylated Proteins

 

INDIVIDUALIZE YOUR CONFERENCE LEARNING EXPERIENCE

- TWO New Workshops
- TWELVE + Case Studies
- FOUR Interactive Panel Discussions and
- FOUR Main Tracks

 


Click here
to view our 2007
FFD Distinguished Speaking Faculty



Click here to view our 2007 Advisory Board.

TWELVE+ Case Studies:

  • Aggregation of Human Monoclonal Antibody during Formulation Development: A Structural Analysis by Vibrational Spectroscopy
  • Different Degradation Pathways in Liquid and Lyophilized Formulations
  • Challenges in the Development of a High Concentration Formulation
  • Confronting the Challenges of Formulation Development, Physical Characterization, and Analytical Evaluation of PEGylated Peptides
  • Structural Studies as a Screening Tool in Optimization of Protein Purification Processes
  • Selecting and Managing a Platform Technology Partner for the Sustained Released of Biomolecules
  • Generation, Identification, and Prevention of Aggregate Formation during Controlled Freeze-Thaw
  • Identify and Analyze Degradants using Mass Spectrometry
  • Investigating Potential Degradation Pathways of Recombinant Glycoproteins
  • Extrapolation of Results from Forced Degradation Studies to Practical Formulation Development
  • Strategies and Limitations of High Throughput Biomolecule Formulation Screening
  • Optimizing Protein Pharmaceutical Formulations with the Use of Second Virial Coefficients Measurements

Bottom menu

Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved

Powered by Interactive Agency Janmedia Interactive, Inc.